Sleeve denied as not FDA-approved for this use by Cigna?

Under Cigna Medical Coverage Policy 0051, Cigna covers bariatric surgery for the treatment of morbid obesity using a covered procedure as medically necessary when ALL specified criteria are met. Sleeve gastrectomy as a stand-alone or staged procedure is included among medically necessary adult bariatric procedures (laparoscopic CPT 43775; open 43843). Adult eligibility requires the individual is ≥18 years of age or has reached full expected skeletal growth AND has evidence of a BMI ≥40, or a BMI 35–39.9 with at least one clinically significant obesity-related comorbidity, plus medical management including evidence of active participation within the last 12 months in a weight-management program supervised by a physician or registered dietician for a minimum of three consecutive months (≥89 days) with monthly documentation. Programs such as Weight Watchers, Jenny Craig, and Optifast are acceptable alternatives if done in conjunction with physician or registered dietician supervision and detailed documentation. Per AACE/ACE/TOS/ASMBS/OMA/ASA 2019 updated guidelines incorporated by Cigna, BMI thresholds are adjusted for individuals of Asian descent. For adolescents, sleeve gastrectomy and Roux-en-Y gastric bypass are the only medically necessary procedures when adolescent-specific criteria are met; all other bariatric procedures in adolescents are considered not medically necessary. Tobacco use should be avoided at all times by all patients; patients who smoke cigarettes should stop, preferably at least six weeks before bariatric surgery. Effective January 15, 2025, the policy clarifies that the coverage statement applies to "initial" surgery, and bariatric surgery for primary treatment of any condition other than morbid obesity is considered not medically necessary.

- Document BMI with serial weight measurements and list each qualifying comorbidity (T2DM, HTN, OSA, GERD, NAFLD, dyslipidemia) with ICD-10 codes; cite the AACE/ACE/TOS/ASMBS/OMA/ASA 2019 guideline endorsement, including adjusted BMI thresholds for Asian patients , which Cigna's own policy incorporates. - Submit a consolidated supervised weight-management log meeting the ≥89-day, monthly-documented, physician- or RD-supervised standard within the last 12 months ; if a commercial program was used, attach physician/RD co-signed notes per Cigna's allowance for Weight Watchers, Jenny Craig, or Optifast with clinician supervision . - Provide letters from a licensed mental health professional (psych clearance) and a registered dietitian (nutritional assessment) dated within 12 months of the request, addressing each ASMBS/AACE preoperative element. - Submit proof of smoking cessation ≥6 weeks pre-op (cotinine test, attestation, cessation program records) to address Cigna's tobacco-cessation expectation ; the 2022 ASMBS/IFSO Indications for Metabolic and Bariatric Surgery support proceeding once cessation is documented. - For Marketplace plan-exclusion denials, request the Summary Plan Description and challenge under state Essential Health Benefit benchmarks; cite the 2022 ASMBS/IFSO guideline recognizing MBS as the most effective evidence-based treatment for clinically severe obesity, supported by STAMPEDE and SLEEVEPASS RCTs showing durable benefit of sleeve gastrectomy. - For "not initial procedure" or revision denials, document the specific complication (stricture, leak, reflux, inadequate weight loss <50% EBWL) meeting Cigna's coverage of takedown for complications and revision/conversion criteria . - For facility/credentialing denials, redirect surgery to an MBSAQIP Comprehensive- or Comprehensive-with-Adolescent-accredited facility , which satisfies Cigna's 3 Star Quality / Center of Excellence requirements.

## Why Cigna Issues a Not-FDA-Approved Denial for Sleeve Gastrectomy

Sleeve gastrectomy is performed using FDA-cleared laparoscopic surgical instruments and has been an established bariatric procedure recognized by the FDA and major surgical societies for many years. A "not-FDA-approved" denial in this context is almost certainly a misclassification — either a coding issue, an administrative error, or a confusion with a different procedure or device. This type of denial is among the most straightforwardly correctable on appeal.

## Why This Denial Is Appealable

The denial rests on a factual premise that is almost always incorrect for sleeve gastrectomy. If Cigna's system flagged this procedure as not FDA-approved, the most likely causes are: (1) an incorrect procedure code was submitted, (2) the denial was triggered by a template rather than a clinical review, or (3) the denial is conflating sleeve gastrectomy with a specific device or technique variant that Cigna's policy addresses differently. In any of these cases, a targeted appeal that documents the regulatory status of the procedure and corrects any coding error has a high likelihood of success.

## Federal Appeal Rights

ERISA §503 and ACA §2719 apply to all adverse benefit determinations, including those based on factual errors. If the internal appeal does not correct the error, external review by an IRO is available. The external review window is typically around four months from the final internal denial — confirm the deadline on your denial letter. If delay poses a health risk, request expedited review.

## Concrete Appeal Steps

1. Review the procedure codes submitted on the original claim or authorization request and confirm they accurately describe sleeve gastrectomy. 2. If a coding error exists, submit a corrected claim or authorization with the correct codes alongside a brief cover letter explaining the correction. 3. File a formal Level 1 internal appeal with a letter from your bariatric surgeon confirming that sleeve gastrectomy is a well-established, FDA-cleared procedure and that the procedure codes submitted are accurate. 4. Request that Cigna identify the specific FDA-approval concern in writing so it can be addressed directly.

## Documentation to Gather

• A letter from your bariatric surgeon affirming the procedure's established regulatory and clinical status.
• The original authorization request or claim with procedure codes, and a corrected version if applicable.
• Your complete diagnosis and clinical records supporting medical necessity (helpful context even for administrative appeals).
• Any Cigna policy language that the denial letter cited, so you can address it specifically.

## Criteria-Mapping Framework

For a not-FDA-approved denial, the criteria map is short: identify the specific regulatory concern Cigna stated, confirm the actual regulatory status of the procedure, and document the correction. If the denial is based on a coding error, the mapping is: denied code → correct code → clinical justification for correct code. Submit this clearly and concisely so the reviewer can resolve the issue without needing additional information.